HHMI is a private biomedical research institution. The investment office is responsible for the institute’s endowment funds.
United States
$23
Erin O'Shea
Donald Koch
Clayton S. Rose
70% Equities
30% Fixed Income
Asset allocation as of August 31, 2024. All information is as per the most recent annual report or other publicly available data via the fund's website
